Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. (Q48019571)

7 February 2018

title

Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. (English)

1 reference

7 February 2018

0 references

10

1 reference

7 February 2018

Elisa De Lazzari

Elisa de Lazzari

6

0 references

Ivo Mueller

11

Ivo Mueller

1 reference

7 February 2018

2

Anna Rosanas-Urgell

1 reference

7 February 2018

9

Pedro L Alonso

1 reference

7 February 2018

8

Peter Siba

1 reference

7 February 2018

Danielle I Stanisic

4

Danielle I Stanisic

1 reference

7 February 2018

Hernando A del Portillo Obando

7

Hernando A Del Portillo

1 reference

7 February 2018

Inoni Betuela

1

Inoni Betuela

1 reference

7 February 2018

Benson Kiniboro

3

Benson Kiniboro

1 reference

7 February 2018

Lornah Samol

5

Lornah Samol

1 reference

7 February 2018

language of work or name

English

0 references

publication date

10 September 2012

1 reference

7 February 2018

Journal of Infectious Diseases

published in

1 reference

7 February 2018

volume

206

1 reference

7 February 2018

page(s)

1771-1780

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The epidemiology of malaria in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Determinants of relapse periodicity in Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Primaquine therapy for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

A trial of combination antimalarial therapies in children from Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Real-world therapies and the problem of vivax malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The distribution of Plasmodium falciparum infection durations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

PLASMODIUM VIVAX CHESSON STRAIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The Chesson strain of Plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

The first Plasmodium vivax relapses of life are usually genetically homologous

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Resistance to therapies for infection by Plasmodium vivax

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

A Research Agenda to Underpin Malaria Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

A research agenda for malaria eradication: drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

Vivax malaria: a major cause of morbidity in early infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS580

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS580

1 reference

7 February 2018

PubMed ID

22966124

1 reference

7 February 2018